[Keratonconjuctivitis sicca with conjunctival shrinkage in the course of Dalzic treatment].
D003228:Conjunctiva / Q000098:blood supply; D003320:Corneal Ulcer / Q000139:chemically induced; D006311:Hearing Disorders / Q000139:chemically induced; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D007637:Keratoconjunctivitis / Q000139:chemically induced*; D008875:Middle Aged; D011217:Practolol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012877:Skin Manifestations; D013666:Tears / Q000378:metabolism; D013997:Time Factors
D011217:Practolol
Keratoconjunctivitis sicca mit Bindehautschrumpfung während einer Behandlung mit Dalzic